SCHEMBL648971

SCHEMBL648971

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(OC(F)(F)F)cc1)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.42
DHFR P00374 3/20 0.42
SERPINE1 P05121 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
CRHR1 P34998 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
MMP13 P45452 1/20 0.36
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
LTB4R2 Q9NPC1 2/20 0.36
P2RX3 P56373 1/20 0.36
UBE2M P61081 2/20 0.35
DCUN1D1 Q96GG9 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TRPV4 Q9HBA0 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138032 0.93 C5AR1 (0.43) C5AR1DHFRSERPINE1CRHR1TRPM8
SCHEMBL650105 0.92 C5AR1 (0.46) C5AR1MEN1KMT2ACRHR1P2RX3
SCHEMBL649510 0.92 NR1H4 (0.46) C5AR1MEN1KMT2ANR1H4CRHR1
SCHEMBL5134680 0.91 C5AR1 (0.43) C5AR1CRHR1
SCHEMBL650285 0.90 C5AR1 (0.41) C5AR1MEN1KMT2ANR1H4CRHR1
SCHEMBL5135486 0.89 C5AR1 (0.42) C5AR1CRHR1MMP13PPARGPPARA
SCHEMBL5136840 0.89 C5AR1 (0.41) C5AR1DHFRCRHR1TRPM8MMP13
SCHEMBL5137638 0.88 C5AR1 (0.41) C5AR1DHFRCRHR1TRPM8MMP13
SCHEMBL5136018 0.88 C5AR1 (0.41) C5AR1DHFRCRHR1TRPM8MMP13
SCHEMBL5136208 0.88 CRHR1 (0.43) C5AR1DHFRCRHR1TRPM8PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed